---
book: Childhood HIV
title: Contents
layout: toc
---

# Contents

*	[Acknowledgements](0-4-acknowledgements.html)
*	[Introduction](0-5-introduction.html)
	*   [About the Bettercare series](0-5-introduction.html#about-the-bettercare-series)
	*   [Why decentralised learning?](0-5-introduction.html#why-decentralised-learning)
	*   [Books in the Bettercare series](0-5-introduction.html#books-in-the-bettercare-series)
	*   [Format of the courses](0-5-introduction.html#format-of-the-courses)
	*   [Contributors](0-5-introduction.html#contributors)
	*   [Updating the course material](0-5-introduction.html#updating-the-course-material)
	*   [Contact information](0-5-introduction.html#contact-information)
{:.prelims}

*	[1. Introduction to childhood HIV infection](1.html)
    *   [Objectives](1.html#objectives)
    *   [Introduction to HIV](1.html#introduction-to-hiv)
    *   [The spread of HIV](1.html#the-spread-of-hiv)
    *   [HIV in society](1.html#hiv-in-society)
    *   [HIV transmission from mother to child](1.html#hiv-transmission-from-mother-to-child)
    *   [Feeding options](1.html#feeding-options)
    *   [Post-exposure prophylaxis](1.html#post-exposure-prophylaxis)
    *   [Case studies](1.html#case-study-1)
*	[2. Clinical and immunological diagnosis of HIV infection](2.html)
    *   [Objectives](2.html#objectives)
    *   [Acute seroconversion illness](2.html#acute-seroconversion-illness)
    *   [Clinical staging of HIV infection](2.html#clinical-staging-of-hiv-infection)
    *   [Confirmation of HIV infection](2.html#confirmation-of-hiv-infection)
    *   [Immunological staging of HIV infection](2.html#immunological-staging-of-hiv-infection)
    *   [Consent for HIV testing](2.html#consent-for-hiv-testing)
    *   [Case studies](2.html#case-study-1)
*	[3. Management of children with HIV infection](3.html)
    *   [Objectives](3.html#objectives)
    *   [Family-centred care](3.html#family-centred-care)
    *   [Routine clinical care](3.html#routine-clinical-care)
    *   [Immunisations](3.html#immunisations)
    *   [Primary prophylaxis](3.html#primary-prophylaxis)
    *   [Nutrition and growth](3.html#nutrition-and-growth)
    *   [Monitoring neurodevelopment](3.html#monitoring-neurodevelopment)
    *   [Monitoring the clinical staging](3.html#monitoring-the-clinical-staging)
    *   [Monitoring immune function](3.html#monitoring-immune-function)
    *   [Screening for HIV-associated infections](3.html#screening-for-hiv-associated-infections)
    *   [Care of adolescents with HIV infection](3.html#care-of-adolescents-with-hiv-infection)
    *   [Disclosure](3.html#disclosure)
    *   [Case studies](3.html#case-study-1)
*	[4. Antiretroviral drugs](4.html)
    *   [Objectives](4.html#objectives)
    *   [Introduction to antiretroviral treatment](4.html#introduction-to-antiretroviral-treatment)
    *   [Classes of antiretroviral drugs](4.html#classes-of-antiretroviral-drugs)
    *   [Standardised treatment regimens](4.html#standardised-treatment-regimens)
    *   [Antiretroviral medication](4.html#antiretroviral-medication)
    *   [Side effects of antiretroviral drugs](4.html#side-effects-of-antiretroviral-drugs)
    *   [Case studies](4.html#case-study-1)
*	[5. Management of children with antiretroviral treatment](5.html)
    *   [Objectives](5.html#objectives)
    *   [Criteria for antiretroviral treatment](5.html#criteria-for-antiretroviral-treatment)
    *   [Patient readiness](5.html#patient-readiness)
    *   [Preparation for antiretroviral treatment](5.html#preparation-for-antiretroviral-treatment)
    *   [Managing antiretroviral treatment](5.html#managing-antiretroviral-treatment)
    *   [Problems with antiretroviral treatment](5.html#problems-with-antiretroviral-treatment)
    *   [Adherence](5.html#adherence)
    *   [Inadequate dosage](5.html#inadequate-dosage)
    *   [Drug resistance](5.html#drug-resistance)
    *   [Treatment failure](5.html#treatment-failure)
    *   [Drug interactions](5.html#drug-interactions)
    *   [Drug interruptions](5.html#drug-interruptions)
    *   [Side effects of antiretroviral agents](5.html#side-effects-of-antiretroviral-agents)
    *   [Immune reconstitution inflammatory syndrome (IRIS)](5.html#immune-reconstitution-inflammatory-syndrome-iris)
    *   [Case studies](5.html#case-study-1)
*	[6. HIV-associated infections and end-of-life care](6.html)
    *   [Objectives](6.html#objectives)
    *   [HIV-associated infections](6.html#hiv-associated-infections)
    *   [Common infections](6.html#common-infections)
    *   [Tuberculosis](6.html#tuberculosis)
    *   [Treating tuberculosis co-infection](6.html#treating-tuberculosis-co-infection)
    *   [End-of-life care](6.html#end-of-life-care)
    *   [Case studies](6.html#case-study-1)

## Tests

*	[1. Introduction to childhood HIV infection](test-1.html)
*	[2. Clinical and immunological diagnosis of HIV infection](test-2.html)
*	[3. Management of children with HIV infection](test-3.html)
*	[4. Antiretroviral drugs](test-4.html)
*	[5. Management of children with antiretroviral treatment](test-5.html)
*	[6. HIV-associated infections and end-of-life care](test-6.html)

*	[Answers](test-answers.html)	
